Surgery Partners Changes Independent Auditor
Ticker: SGRY · Form: 8-K · Filed: Aug 23, 2024 · CIK: 1638833
| Field | Detail |
|---|---|
| Company | Surgery Partners, Inc. (SGRY) |
| Form Type | 8-K |
| Filed Date | Aug 23, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
Related Tickers: SGRY
TL;DR
Surg Partners swapped auditors from EY to PwC, effective Aug 21.
AI Summary
Surgery Partners, Inc. filed an 8-K on August 23, 2024, reporting a change in its certifying accountant. The company, incorporated in Delaware with its principal executive offices in Brentwood, Tennessee, has appointed PricewaterhouseCoopers LLP as its new independent registered public accounting firm, effective August 21, 2024. This change follows the resignation of Ernst & Young LLP.
Why It Matters
A change in auditors can signal potential concerns about past financial reporting or a desire for a fresh perspective on the company's financial health.
Risk Assessment
Risk Level: medium — A change in auditor, especially if it follows disagreements or issues, can indicate underlying financial or accounting concerns.
Key Players & Entities
- Surgery Partners, Inc. (company) — Registrant
- PricewaterhouseCoopers LLP (company) — New Independent Registered Public Accounting Firm
- Ernst & Young LLP (company) — Former Independent Registered Public Accounting Firm
- August 21, 2024 (date) — Effective date of change in accountant
- August 23, 2024 (date) — Filing date of the 8-K
FAQ
When was the change in certifying accountant effective?
The change in certifying accountant was effective August 21, 2024.
Who is the new independent registered public accounting firm for Surgery Partners, Inc.?
PricewaterhouseCoopers LLP is the new independent registered public accounting firm.
Who was Surgery Partners, Inc.'s previous independent registered public accounting firm?
Ernst & Young LLP was Surgery Partners, Inc.'s previous independent registered public accounting firm.
What form was filed to report this change?
A Form 8-K was filed to report this change.
What is the principal executive office location for Surgery Partners, Inc.?
The principal executive offices are located in Brentwood, Tennessee.
Filing Stats: 851 words · 3 min read · ~3 pages · Grade level 14.3 · Accepted 2024-08-23 16:18:52
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share SGRY The Nasdaq Global Select
Filing Documents
- sgry-20240821.htm (8-K) — 27KB
- changeinauditorresponselet.htm (EX-16) — 2KB
- 0001638833-24-000137.txt ( ) — 151KB
- sgry-20240821.xsd (EX-101.SCH) — 2KB
- sgry-20240821_lab.xml (EX-101.LAB) — 21KB
- sgry-20240821_pre.xml (EX-101.PRE) — 12KB
- sgry-20240821_htm.xml (XML) — 3KB
01. Changes in Registrant's Certifying Accountant
Item 4.01. Changes in Registrant's Certifying Accountant. (a) On August 21, 2024, Surgery Partners, Inc. (the "Company"), through action of the Audit Committee of the Board of Directors of the Company (the "Audit Committee"), dismissed Deloitte & Touche LLP ("Deloitte") as the Company's independent registered public accounting firm, effective as of August 21, 2024. The reports of Deloitte on the Company's consolidated financial statements for the fiscal years ended December 31, 2023 and 2022 did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. During the fiscal years ended December 31, 2023 and 2022 and the subsequent interim period through the date of dismissal, there were no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) between the Company and Deloitte on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to Deloitte's satisfaction, would have caused Deloitte to make reference to the subject matter of the disagreements in its reports on the Company's consolidated financial statements for such years. During the fiscal years ended December 31, 2023 and 2022 and the subsequent interim period through the date of dismissal, there have been no reportable events (as defined in Item 304(a)(1)(v) of Regulation S-K). The Company provided Deloitte with a copy of this Current Report on Form 8-K prior to filing with the Securities and Exchange Commission ("SEC") and requested that Deloitte furnish a letter addressed to the SEC stating whether or not it agrees with the statements made by the Company. A copy of Deloitte's letter, dated August 21, 2024 is filed as Exhibit 16 to this Current Report on Form 8-K. (b) On August 21, 2024, the Company, through action of the Audit Committee, engaged Ernst & Young LLP ("EY") as th
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits: 16 L etter from Deloitte & Touche LLP, dated A ugust 21, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SURGERY PARTNERS, INC. By: /s/ David T. Doherty David T. Doherty Executive Vice President, Chief Financial Officer Date: August 23, 2024